The current price-to-earnings ratio for Boston Scientific stock as of Nov 21, 2024 is 75.0. This is calculated based on the current EPS of $1.22 and the stock price of $91.5 per share. The P/E ratio has increased by 24% from the past four quarters average of 60.4.
The average historical PE ratio of Boston Scientific for the last nine years is 92.81. The current PE ratio of 75.0 is 19% below the historical average. In the past nine years, BSX's PE ratio was at its highest in the Sep 2016 quarter at 396.67, when the stock price was $23.8 and the EPS was $0.06. The lowest value was in the Mar 2020 quarter, when it reached 10.59 with a price of $32.63 and an EPS of $3.08.
Maximum annual increase: 272.5% in 2017
Maximum annual decrease: -90.57% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 53.53 | -47.94% |
2022 | 102.82 | 67% |
2021 | 61.57 | N/A |
2020 | N/A | N/A |
2019 | 13.38 | -54.19% |
2018 | 29.21 | -90.57% |
2017 | 309.88 | 272.5% |
2016 | 83.19 | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
The current PE ratio of BSX is greater than its 3 and 5-year historical averages, but it is lower than the 10-year average.
BSX's PE ratio is higher than its peer stocks SYK and MDT. Boston Scientific's current PE ratio of 75.0 is above the average of its peers, which is 30.85.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 10.14 | $41.51B |
CNMD CONMED Corp | 16.75 | $2.22B |
MDT Medtronic plc | 28.44 | $108.68B |
TFX Teleflex Inc | 37.68 | $8.85B |
SYK Stryker Corp | 41.37 | $148.73B |
MMSI Merit Medical Systems Inc | 50.74 | $6.12B |
BSX Boston Scientific Corp | 75 | $134.86B |
ANGO Angiodynamics Inc | N/A | $282.41M |
As of Nov 21, 2024, BSX stock has a price to earnings ratio of 75.
As an average over the last 3 years, BSX stock has a PE ratio of 74.18.
As an average over the last 5 years, BSX stock has a PE ratio of 73.1.
Over the last nine years, the quarterly PE ratio reached a historic high of 396.67 in the Sep 2016 quarter.
The current price to earnings ratio of BSX is 19% lower than the 9-year historical average.
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 21, 2024), Boston Scientific's stock price is $91.5. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.22. Therefore, Boston Scientific's P/E ratio for today is 75. PE RATIO(75) = STOCK PRICE($91.5) / TTM EPS($1.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.